Author,Title,Journal,ISSN,Publisher,Date,Volume,Number,Page,URL,URL(DOI)
Naoki Haratake and Hidetoshi Hayashi and Mototsugu Shimokawa and Yusuke Nakano and Koichi Azuma and Masahide Oki and Keiichi Ota and Hiroshige Yoshioka and Tomohiro Sakamoto and Nobuyuki Yamamoto and Kazuhiko Nakagawa and Takashi Seto,Phase III Clinical Trial for the Combination of Erlotinib Plus Ramucirumab Compared With Osimertinib in Previously Untreated Advanced or Recurrent Non–Small Cell Lung Cancer Positive for the L858R Mutation of EGFR: REVOL858R (WJOG14420L),Clinical Lung Cancer,1525-7304,Elsevier BV,2022-05-01,23,,e257-e263,https://cir.nii.ac.jp/crid/1872272493149315712,https://doi.org/10.1016/j.cllc.2021.10.007